DE602004030112D1 - Verfahren zur herstellung von ace hemmern - Google Patents

Verfahren zur herstellung von ace hemmern

Info

Publication number
DE602004030112D1
DE602004030112D1 DE602004030112T DE602004030112T DE602004030112D1 DE 602004030112 D1 DE602004030112 D1 DE 602004030112D1 DE 602004030112 T DE602004030112 T DE 602004030112T DE 602004030112 T DE602004030112 T DE 602004030112T DE 602004030112 D1 DE602004030112 D1 DE 602004030112D1
Authority
DE
Germany
Prior art keywords
preparation
ace inhibitors
amino acid
activated
ace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004030112T
Other languages
English (en)
Inventor
Branko Jenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals dd filed Critical Lek Pharmaceuticals dd
Publication of DE602004030112D1 publication Critical patent/DE602004030112D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602004030112T 2003-05-16 2004-05-07 Verfahren zur herstellung von ace hemmern Expired - Lifetime DE602004030112D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200300123A SI21507A (sl) 2003-05-16 2003-05-16 Postopek za pripravo spojin z ace inhibitornim delovanjem
PCT/SI2004/000021 WO2004101515A1 (en) 2003-05-16 2004-05-07 A process for the preparation of compounds having an ace inhibitory action

Publications (1)

Publication Number Publication Date
DE602004030112D1 true DE602004030112D1 (de) 2010-12-30

Family

ID=33448812

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030112T Expired - Lifetime DE602004030112D1 (de) 2003-05-16 2004-05-07 Verfahren zur herstellung von ace hemmern

Country Status (7)

Country Link
US (1) US7671215B2 (de)
EP (1) EP1628956B1 (de)
AT (1) ATE488498T1 (de)
DE (1) DE602004030112D1 (de)
RU (1) RU2377236C2 (de)
SI (2) SI21507A (de)
WO (1) WO2004101515A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2468724T3 (en) * 2006-12-21 2016-02-22 Zealand Pharma As Synthesis of pyrrolidine compounds
US20090076126A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched enalapril
CA2768239A1 (en) 2009-07-16 2011-01-20 Abbott Laboratories Processes for the synthesis of (2s, 3ar, 7as)-octahydro-1h-indole carboxylic acid as an intermediate for trandolapril
WO2014057404A1 (en) * 2012-10-10 2014-04-17 Piramal Enterprises Limited An improved process for preparation of perindopril intermediate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE289543C (de) 1913-08-18
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US5864040A (en) 1996-01-11 1999-01-26 American Home Products Corporation Benzimidazole phosphono-amino acids
GB9710612D0 (en) 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
IL151923A0 (en) 2000-03-31 2003-04-10 Pfizer Prod Inc Novel piperazine derivatives
GB2375762B (en) * 2001-05-21 2003-10-01 Fermenta Biotech Ltd Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters
WO2002094857A1 (en) * 2001-05-23 2002-11-28 The Curators Of The University Of Missouri Inverse solid phase synthesis of peptides
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
GB0119795D0 (en) 2001-08-14 2001-10-03 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
US20070072919A1 (en) 2007-03-29
SI21507A (sl) 2004-12-31
EP1628956B1 (de) 2010-11-17
EP1628956A1 (de) 2006-03-01
SI1628956T1 (sl) 2011-03-31
RU2377236C2 (ru) 2009-12-27
ATE488498T1 (de) 2010-12-15
US7671215B2 (en) 2010-03-02
WO2004101515A1 (en) 2004-11-25
RU2005139158A (ru) 2007-06-27

Similar Documents

Publication Publication Date Title
RU2345065C2 (ru) Ингибиторы протеаз, расщепляющих за пролином
DE50310614D1 (de) Verfahren zur herstellung von c13-alkoholgemischen
NZ611150A (en) Process and fluid to improve the permeability of sandstone formations using a chelating agent
ATE550319T1 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
DE60311869D1 (de) Kristalline cefdinirsalze
ATE430572T1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
ATE493110T1 (de) Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
EA200701852A1 (ru) Производные аминокислот
DE602004030112D1 (de) Verfahren zur herstellung von ace hemmern
DE502005009501D1 (de) Verfahren zur herstellung von candesartan
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
DE69933030D1 (de) Verfahren zur hemmung von korrosion unter verwendung von isomeren des chlormethylbenzotriazols
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ATE500219T1 (de) Neue dipeptidylpeptidase-iv-inhibitoren und verfahren zur ihrer herstellung und pharmazeutische zusammensetzung, die diese enthalten
ATE250057T1 (de) Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten
ATE451452T1 (de) Verfahren zur enzymatischen reduktion von alkinderivaten
DE602006013970D1 (de) Verfahren zur herstellung substituierter pyrimidine
DE602004011921D1 (de) Verfahren zur herstellung von (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitril und dessen derivaten
NO20073717L (no) Fenylmetanonderivater og deres anvendelse som glycin-transportor-1-inhibitorer
DE602004014822D1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN